2 ArticlesNifty Pharma
1 / 1
FDA’s New Rules Propels Generic and Biosimilar Approvals
Effective January 9th 2017, the US Food and Drug Administration (FDA) has announced an amendment to the final rule ((the rule governs the manner in which FDA ...
Premium: US Investigation Into Price Collusion Haunts Indian Drug Manufacturers
In a major setback for Pharma companies, Bloomberg has confirmed from its sources that U.S. Prosecutors have begun to make headway in the 2 year investigation ...
